Medical Devices DECODED
Previous edition: 10 May 2024
Share article
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
OrthoXel's Vertex Hip Fracture Nail system obtains US clearance
OrthoXel’s system aims to provide a stable and versatile solution for surgeons.
OrthoXel has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its Vertex Hip Fracture Nail (HFN), designed to improve hip fracture treatment.
The Vertex HFN is designed to address common challenges faced in hip fracture management such as instability and high cutout rates, which can impede patient recovery and mobility.
OrthoXel’s system aims to provide a stable and versatile solution for surgeons, enhancing the surgical procedure and potentially improving patient outcomes.
The system features two proximal interdigitating screws for enhanced fixation and a radially fluted nail stem for rotational stability, particularly in critical regions of the femur.
Furthermore, the Vertex HFN includes three proximal construct options, allowing for customisation based on intra-operative requirements.
These options include two interdigitating lag screw configurations with different placements and a solid lag screw for a more traditional approach.
OrthoXel said the intuitive design of the Vertex system allows it to be integrated seamlessly into existing surgical workflows.
The implants and instruments come with radiographic guides and cues for better visualisation during surgery, simplifying the process for medical professionals.
Baylor College of Medicine in Houston orthopaedic surgery chairman Douglas Dirschl was involved in the product development with OrthoXel.
Dirschl said: “The Vertex's design offers enhanced stability as well as the flexibility to tailor treatment to individual patient and fracture needs.
“Like with their Apex nail, the OrthoXel team has once again demonstrated excellence and innovation in product design.”
University of Chicago Medicine residency programme director and orthopaedic trauma director Jason Strelzow also contributed to the development of the Vertex system.
Strelzow said: “Working with the development team they have created a one-of-a-kind system taking advantage of the existing knowledge of hip fracture nails and generated a novel, innovative design that addresses the biggest concerns around hip fracture fixation.
“The fluted interference fit, combined with enhanced head/neck fixation through the interdigitating screw design provides an exciting and potentially game-changing tool for these injuries.”
Latest news
Neuralink's first brain chip implant faces setback
Despite the partial retraction, the patient was still able to use the implant to play chess on a computer using his thoughts.
Tandem's insulin pump app glitch triggers FDA Class I recall
Tandem’s insulin pump iOS app crash caused the pump’s battery to drain and shut down resulting in 224 reported injuries leading to a Class I recall.
R3 Vascular secures funding to support bioresorbable scaffold trial
The company’s bioresorbable scaffolds are crafted from an ultra-high molecular weight polylactic acid polymer.
UK MHRA pilots AI Airlock regulatory sandbox
The MHRA has set out a system designed to test AI-driven devices in isolation, aimed at laying the groundwork for future regulation.
Freyja wins FDA clearance for VereSee device
The VereSee device is a 2mm abdominal-access video-entry device designed for laparoscopic surgery in women’s health.
ProAxsis awarded Innovate UK grant for respiratory monitoring
The grant will be used to develop ProAxsis’s respiratory diagnostics point-of-care range.
Reflow Medical eyes follow-up data in retrievable stent trial
Already CE marked, Reflow has completed enrolment in a US trial for its retrievable stent therapy device.
In our previous edition
Medical Devices Decoded
FDA issues warning on Getinge device amid quality concerns
09 May 2024
Medical Devices Decoded
Samsung to acquire foetal ultrasound AI software company Sonio
08 May 2024
Medical Devices Decoded
Medtronic's renal denervation system receives approval in China
07 May 2024
Newsletters in other sectors
Aerospace, Defence & Security
Automotive
Banking & Payments
Medical Devices
Travel and Tourism
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer